![John Green](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Green
Directeur Financier/CFO chez
COGENT BIOSCIENCES, INC.
Fortune : 3 M $ au 30/06/2026
Profil
John L.
Green is currently Chief Financial Officer at Cogent Biosciences, Inc. Formerly, Mr. Green was Chief Financial Officer & Accounting Director at Dicerna Pharmaceuticals, Inc. from 2014 to 2020, Assurance Manager at PricewaterhouseCoopers LLP from 2008 to 2013, Vice President & Assistant Treasurer at TSI Corp from 1989 to 1994, Chief Accounting Officer at Merrimack Pharmaceuticals, Inc. from 2017 to 2018, Vice President-Finance at On-Q-ity, Inc. from 2011 to 2012, Senior Manager at Corporate Finance Group, Inc. from 2013 to 2014, Chief Financial Officer at Verastem, Inc. from 2013 to 2016, Controller at Fractyl Health, Inc. from 2015 to 2017, and Chief Financial Officer & Senior Vice President at rEVO Biologics, Inc. from 2002 to 2010.
Education includes undergraduate studies at College of the Holy Cross (Massachusetts) and Acadia University, and an MBA from Questrom School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/04/2026 | 81 834 ( 0,05% ) | 3 M $ | 30/06/2026 |
Postes actifs de John Green
| Sociétés | Poste | Début |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Directeur Financier/CFO | 01/06/2018 |
Anciens postes connus de John Green
| Sociétés | Poste | Fin |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 26/05/2020 |
| MERRIMACK PHARMACEUTICALS | Comptroller/Controller/Auditor | 01/06/2018 |
| FRACTYL HEALTH, INC. | Comptroller/Controller/Auditor | 01/03/2017 |
| VERASTEM, INC. | Directeur Financier/CFO | 15/04/2016 |
Corporate Finance Group, Inc.
 Corporate Finance Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides accounting, tax, business advisory and cybersecurity services | Corporate Officer/Principal | 01/06/2014 |
Formation de John Green
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TSI Corp
 TSI Corp Miscellaneous Commercial ServicesCommercial Services Provides lab testing services | Commercial Services |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Acadia University
 Acadia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
On-Q-ity, Inc.
 On-Q-ity, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic services for cancer | Health Services |
Corporate Finance Group, Inc.
Corporate Finance Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides accounting, tax, business advisory and cybersecurity services | Commercial Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Fractyl Health, Inc.
 Fractyl Health, Inc. BiotechnologyHealth Technology Develops and sells therapeutics for metabolic diseases, type 2 diabetes and obesity | Health Technology |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
Questrom School of Business
 Questrom School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
